Updates shares in paragraph 2, adds background from paragraph 5 onward
Feb 21 (Reuters) - The U.S. Justice Department has launched an investigation into UnitedHealth's UNH.N Medicare billing practices in recent months, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Shares of the company fell nearly 10% in premarket trading. Shares of other health insurers also fell before the bell.
The new civil fraud investigation is examining UnitedHealth's practices for recording diagnoses that trigger extra payments to its Medicare Advantage plans, including at physician groups the insurance giant owns, the report added.
DoJ and UnitedHealth did not immediately respond to Reuters requests for comment.
Medicare Advantage plans are offered by private insurers who are paid a set rate by the U.S. government to manage healthcare for older people looking for extra benefits not covered in the regular Medicare coverage. The DoJ has a long-running lawsuit pending against UnitedHealth over Medicare Advantage.
The department had also sued to block UnitedHealth's $3.3 billion acquisition of Amedisys Inc AMED.O, citing concerns that the deal would reduce competition in the home health services market.
UnitedHealth runs the country's largest health insurer, UnitedHealthcare, as well as pharmacy benefit manager Optum and medical practices.
The company and its peers, who provide government-backed Medicare and Medicaid insurance plans for low-income individuals, have seen an increase in medical costs over the last few quarters.
The company also encountered other challenges last year, including a cyberattack on its tech division Change Healthcare and a backlash over denial of insurance claims after the murder of UnitedHealthcare CEO Brian Thompson.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
((Sriparna.Roy@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。